2017-06-302026-03-272017-06-302001Juan Carlos Bautista Ramírez0920-121110.1016/S0920-1211(01)00187-5https://doi.org/10.1016/S0920-1211(01)00187-5https://repositorio.inprf.gob.mx/handle/123456789/7019engacceso cerradoAdenosine-Analogs & derivativesAdenosine-PharmacologyAnalgesics, Opioid - PharmacologyAnimalsBehavior, Animal- Drug effectsBehavior, Animal-PhysiologyExcitatory Amino Acid AgonistsKainic AcidMaleMorphine-PharmacologyRatsRats, WistarReceptors, Opioid, mu - Drug effectsReceptors, Opioid, mu - MetabolismReceptors, Purinergic P1 - Drug effectsReceptors, Purinergic P1 - MetabolismStatus Epilepticus-Chemically inducedStatus Epilepticus-MetabolismUp-Regulation-Drug effectsUp-Regulation-PhysiologyAnalgesics, OpioidExcitatory Amino Acid AgonistsReceptors, Opioid, muReceptors, Purinergic P1N(6)-cyclopentyladenosineMorphineAdenosineKainic AcidEffects of chronic morphine and N(6)-cyclopentyl-adenosine administration on kainic acid-induced status epilepticus.article2-3Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz89-96Países Bajos44